» Articles » PMID: 27347031

Anti-inflammatory Effects of Oroxylin A on RAW 264.7 Mouse Macrophages Induced with Polyinosinic-polycytidylic Acid

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2016 Jun 28
PMID 27347031
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Oroxylin A (5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one; Baicalein 6-methyl ether) is an active flavonoid compound originally isolated from Scutellaria radix, which has been used to treat pulmonary infection in Korea, China, and Japan. Oroxylin A is known to possess dopamine reuptake inhibitor activity. However, the effects of oroxylin A on virus-induced macrophages has not been fully elucidated. In the present study, the anti-inflammatory effects of oroxylin A on double-stranded RNA-induced macrophages were examined. Production of nitric oxide (NO), various cytokines, as well as calcium release and the mRNA expression of signal transducer and activator of transcription 1 (STAT1) in dsRNA polyinosinic-polycytidylic acid (PIC)-induced RAW 264.7 mouse macrophages were evaluated. Oroxylin A restored the cell viability in PIC-induced RAW 264.7 mouse macrophages at concentrations of up to 50 µM. Additionally, oroxylin A significantly inhibited the production of nitric oxide (NO), interleukin (IL)-1α, IL-1β, IL-6, IL-10, interferon gamma-induced protein 10, granulocyte-colony stimulating factor (CSF), granulocyte macrophage-CSF, leukemia inhibitory factor (IL-6 class cytokine), lipopolysaccharide-induced CXC chemokine (LIX), monocyte chemoattractant protein 1, macrophage inflammatory protein (MIP)-1α, MIP-1β, MIP-2, Regulated on Activation, Normal T Expressed and Secreted, tumor necrosis factor-α, and vascular endothelial growth factor as well as calcium release and the mRNA expression of STAT1 in PIC-induced RAW 264.7 cells (P<0.05). Thus, the present results suggest that oroxylin A has anti-inflammatory properties, associated with its inhibition of NO, cytokines, chemokines and growth factors in PIC-induced macrophages via the calcium-STAT pathway.

Citing Articles

A Comparative Study of Two (L.) Kurz. Phenotypes Based on Phytochemicals and Antioxidant Effects, and the Anti-Inflammatory Activity of Leaf and Pod Extracts.

Panomai P, Thapphasaraphong S, Nualkaew N Plants (Basel). 2024; 13(15).

PMID: 39124228 PMC: 11314318. DOI: 10.3390/plants13152110.


SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process.

Lambona C, Zwergel C, Valente S, Mai A J Med Chem. 2024; 67(3):1662-1689.

PMID: 38261767 PMC: 10859967. DOI: 10.1021/acs.jmedchem.3c01979.


Computer-aided drug design combined network pharmacology to explore anti-SARS-CoV-2 or anti-inflammatory targets and mechanisms of Qingfei Paidu Decoction for COVID-19.

Wang Z, Zhan J, Gao H Front Immunol. 2023; 13:1015271.

PMID: 36618410 PMC: 9816407. DOI: 10.3389/fimmu.2022.1015271.


Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives.

Tuli H, Garg V, Kumar A, Aggarwal D, Anand U, Parashar N Naunyn Schmiedebergs Arch Pharmacol. 2022; 396(2):191-212.

PMID: 36214865 DOI: 10.1007/s00210-022-02298-0.


Flavonoids as Potential Anti-Inflammatory Molecules: A Review.

Al-Khayri J, Sahana G, Nagella P, Joseph B, Alessa F, Al-Mssallem M Molecules. 2022; 27(9).

PMID: 35566252 PMC: 9100260. DOI: 10.3390/molecules27092901.


References
1.
Yoon S, Lee Y, Park S, Kim H, Bae H, Kim H . Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. J Ethnopharmacol. 2009; 125(2):286-90. DOI: 10.1016/j.jep.2009.06.027. View

2.
Canna S, de Jesus A, Gouni S, Brooks S, Marrero B, Liu Y . An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014; 46(10):1140-6. PMC: 4177369. DOI: 10.1038/ng.3089. View

3.
Lee J, Park W . Anti-inflammatory effect of myristicin on RAW 264.7 macrophages stimulated with polyinosinic-polycytidylic acid. Molecules. 2011; 16(8):7132-42. PMC: 6264243. DOI: 10.3390/molecules16087132. View

4.
Riedemann N, Neff T, Guo R, Bernacki K, Laudes I, Sarma J . Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol. 2002; 170(1):503-7. DOI: 10.4049/jimmunol.170.1.503. View

5.
Wareing M, Lyon A, Lu B, Gerard C, Sarawar S . Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol. 2004; 76(4):886-95. DOI: 10.1189/jlb.1203644. View